Marc Chimowitz to Ischemic Attack, Transient
This is a "connection" page, showing publications Marc Chimowitz has written about Ischemic Attack, Transient.
Connection Strength
3.332
-
Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
Score: 0.609
-
Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
Score: 0.435
-
In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial? Neurosurgery. 2014 Feb; 74(2):E235-6.
Score: 0.400
-
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
Score: 0.339
-
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
Score: 0.335
-
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb; 30(2):105504.
Score: 0.161
-
Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10):105051.
Score: 0.156
-
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
Score: 0.112
-
Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke. 2015 Sep; 46(9):2562-7.
Score: 0.111
-
Ischemic stroke and TIA: clinical clues to common causes. Geriatrics. 1994 Jun; 49(6):37-42.
Score: 0.102
-
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul; 45(7):2160-236.
Score: 0.102
-
Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008 Jun; 65(6):733-7.
Score: 0.068
-
Is there a role for heparin in the management of complications of subarachnoid hemorrhage? Stroke. 1987 Nov-Dec; 18(6):1169-72.
Score: 0.065
-
Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
Score: 0.064
-
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005 Mar 31; 352(13):1305-16.
Score: 0.054
-
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
Score: 0.049
-
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003 Sep; 34(9):2310-22.
Score: 0.049
-
Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
Score: 0.031
-
Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
Score: 0.027
-
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
Score: 0.025
-
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
Score: 0.020
-
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
Score: 0.018